- Sophie Weatherhead, Wellcome clinical training fellow1,
- Stephen C Robson, professor of fetal medicine2,
- Nick J Reynolds, professor of dermatology1
- 1Dermatological Sciences, Institute of Cellular Medicine, Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne
- 2Uterine Cell Signalling Group, Institute of Cellular Medicine
- Correspondence to: N J Reynolds N.J.Reynolds{at}ncl.ac.uk
Introduction
Atopic eczema has a reported lifetime prevalence of 8-17% in adults aged under 60.1 It is more common in women, affecting 16% in the United Kingdom, and in adults has its highest prevalence between the ages of 16 and 24.2 The incidence of eczema seems to be generally increasing, particularly in children.3 4 Moderate to severe eczema can be particularly difficult to manage, and second line treatments are often needed to control it.5
As the scenario suggests, treatment options become limited when a patient decides to try to conceive, and disease control is often suboptimal. This article discusses management of eczema and the important implications in pregnancy.
SCENARIO
A 26 year old woman with lifelong moderate to severe atopic eczema had been unable to achieve good disease control with topical drugs. She received narrow band ultraviolet B phototherapy in 2001 but relapsed within a short time. As part of a randomised controlled trial she received 12 weeks of azathioprine,6 on which she greatly improved. She subsequently failed to respond to topical tacrolimus but received two further courses of azathioprine, both with an excellent response.
Six months after stopping azathioprine she became pregnant, and her eczema quickly flared. This was managed with potent topical steroids, although her disease remained troublesome throughout the pregnancy. After the birth of her child, her eczema was managed with methotrexate with a good response.
Methods
We searched national health information sources, the Cochrane database and PubMed up to March 2007. Key search words used included “atopic dermatitis”, “eczema”, “pregnancy”, “maternal”, and “breastfeeding”. We used our personal archive of references and sought advice from the National Teratology Information Service, Drug Information …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012